BD Unveils FACSLyric™ Flow Cytometer at the First National Cell Analysis Academic Conference in China

Chongqing, October 201929October 24, 2019 /PRNewswire/ -- BD, a global leader in medical technology and the leader in flow cytometry,The 1st National Annual Academic Conference on Cell AnalysisMajor Announcement: BD FACSLyric, Another Innovative Tool for Life Science Research in China^TMFlow Cytometer. FACSLyric^TMFlow cytometry has not only seen significant improvements in analysis speed, resolution, and accuracy but also enables the mutual transfer of experimental and analytical templates, as well as mutual recognition of inter-laboratory data reports. For the first time, it has opened the door to managing multiple subordinate laboratories under "a single standard," promotingChinaNational Laboratory Medical Consortium: From Vision to Reality

The National Annual Academic Conference on Cell Analysis Establishes a High Ground for Academic Research in the Field of Cell Studies

As a global research hotspot, biotechnology has played a crucial role in unveiling the mysteries of human life and driving breakthroughs in medical research. To further strengthenChinaThe First National Academic Annual Conference on Cell Analysis, hosted by the Cell Analysis Professional Committee of the Chinese Society for Biotechnology, was grandly held in Chongqing. The conference aimed to advance the development of cell analysis disciplines and comprehensive diagnostic capabilities for hematologic diseases in China, while promoting international exchange and cooperation in areas such as the clinical application of cell analysis technologies and basic research on biotherapy. Distinguished experts from domestic and international fields of cytology were invited to attend, engaging in in-depth discussions on current hot topics, including hematopathological morphology, cellular immunology, molecular genetics, and the application of flow cytometry in single-cell gene sequencing and protein functional engineering.

Professor Liu Yanrong, Chair of the Conference and Director of the Hematology Cell Laboratory at the Institute of Hematology, Peking University, stated, “In recent years, China has continuously achieved breakthrough progress and results in the field of life sciences, occupying an increasingly important position in global research. Cell biology is the foundation of both basic and clinical medicine, as the study of all life phenomena is inseparable from the study of cells. The National Annual Conference on Cell Analysis integrates advanced technologies, rich experience, and typical cases from interdisciplinary fields for exchange and sharing, which facilitates mutual learning and collaborative advancement across the entire scientific community.”

“One Central Control Hub” Integrated with “Multiple Replicable” Subordinate Laboratories to Create an Interconnected Laboratory Solution

This time, BD brought its latest model FACSLyric^TMFlow cytometry made its debut at the inaugural National Annual Conference on Cell Analysis, where the concept of building a clinical laboratory medical consortium through “standardized” settings and “homogenized” management models was proposed for the first time. It can play an important role in fields such as immunological research and hematologic diseases, drawing widespread attention from scientists and clinical medical experts present.

At a time when traditional biochemical and immunological testing has already achieved standardization, inter-laboratory standardization in conventional flow cytometry still has a long way to go due to its complexity and variability in instrument results. The so-called“"Standardization" refers to the process by which experiments conducted at different times, locations, and with different instruments yield identical test results. For example, first select the laboratory of a certain Grade A tertiary hospital as“Central Laboratory,” peripheral laboratories in various regions can, according to“The experimental template of the "Central Laboratory" can be imported via email or USB drive, completing standardized system and experiment setup. Under identical settings, BD FACSLyric^TM will yield completely consistent test results. In other words, on the one hand, regional laboratories can report test results to the central laboratory to obtain more professional and authoritative guidance on data interpretation; on the other hand, patients at“Test reports generated “at your doorstep” will be recognized by higher-level hospitals, eliminating the hassle of duplicate testing and significantly saving on medical costs and time.

Flow cytometry is a specialized technique for cell phenotyping, sorting, and analysis, which also demands a high level of professional expertise from operators. Due toChinaThe uneven distribution of medical resources in China is not limited to hardware and technology; there is an even more severe disparity in the technical proficiency of healthcare professionals.

To address the barriers to the implementation of tiered diagnosis and treatment, such as insufficient healthcare resources, inadequate service capacity in primary healthcare institutions, and the lack of effective communication channels among medical institutions, strengthening the construction of medical consortia plays a significant role in promoting the ultimate realization of tiered diagnosis and treatment.

Lu Wen, Vice President of BD’s Biosciences business in Greater China, stated, “Over the past 25 years of being rooted in China, BD has accompanied and witnessed the development of China’s biotechnology industry. As a trusted partner in the field of life sciences research in China, BD deeply understands the urgent needs for the development of primary healthcare and precise laboratory testing in China. We are committed to responding to the national call for accelerating the construction of close-knit medical consortia by providing efficient, accurate, and standardized laboratory connectivity solutions. In the short term, we aim to offer effective solutions to facilitate the establishment of laboratory-based medical alliances, thereby contributing to the implementation of the tiered diagnosis and treatment system.””

Breaking the Cocoon to Rebirth: Multiple Technologies Set New Industry Benchmarks

“Flow cytometry is a cell analysis technique that involves detecting cells after they have been labeled with fluorescent markers,” explained Professor Wang Huijun, head of the Flow Cytometry Laboratory at the Pathology Center of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences. “The higher the detection sensitivity and resolution of the fluorescence channels, the clearer the cell clustering, enabling the identification of more weakly positive or small clonal populations.”

BDProprietary patents and unique optical path design for FACSLyric^TMDelivers instrument resolution superior to industry standards; with a sample analysis speed of up to 35,000 cells per second, it holds a leading advantage in the analysis of microscopic particles (such as cells, bacteria, viruses, and nanoparticles).

BD FACSLyric: Continuously Breaking Through Boundaries^TMIt breaks the current "loading limitation" of traditional flow cytometers, which requires samples to be transferred into flow cytometry tubes beforehand. Equipped with a universal automatic sampler, it enables direct on-board detection of samples from up to 21 types of carriers. It reduces the cross-contamination rate that may occur during the transition between consecutive samples to the lowest level in the industry, thereby better ensuring the accuracy of experimental results. Due to its excellent resolution and extremely low cross-contamination rate, this groundbreaking product offers unique analytical advantages for special and precious clinical samples, such as those involving minimal residual disease or ultra-low abundance targets.

Consistently High-Quality Configuration, FACSLyric^TMAutomated adjustment compensation, easy quality control, daily monitoring of instrument status, ensuring the accuracy and stability of all sample results from the source. In the future, FACSLyric^TMIt will also achieve interconnection with the Hospital Information Management System, enabling real-time sharing of experimental data within the hospital's internal systems.

As a global leader in flow cytometry, BD also bears the historic mission of driving technological innovation and iterative advancement in the field. With over 120 years of craftsmanship, BD will continue to scale new scientific heights, build upon its established milestones to pioneer novel solutions, and deliver more remarkable technologies to life science research in China.